Newsroom | Top Stories | Abbott U.S.
Jun 26, 2024 · Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
Abbott MediaRoom - Press Releases
Nov 19, 2024 · Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'
Abbott Laboratories (ABT) Latest Stock News & Headlines
Get the latest Abbott Laboratories (ABT) stock news and headlines to help you in your trading and investing decisions.
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint …
ABBOTT PARK, Ill., Oct. 16, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2024. Third-quarter GAAP diluted EPS of $0.94 and adjusted diluted EPS of $1.21, which excludes specified items.
Abbott Receives U.S. FDA Clearance for Two New Over-the …
ABBOTT PARK, Ill., June 10, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used b...
Newsroom | Top Stories | Abbott U.S.
Dec 12, 2023 · Abbott Receives CE Mark for its Groundbreaking Assert-IQ™ Insertable Cardiac Monitor, Expanding Availability of Long-Term Monitoring for Irregular Heart Rhythms
View All Stories | Newsroom | Abbott U.S.
Keep up with the latest Abbott news and event information, and download assets for the news media and the public.
Strong Performance by Abbott’s Base Business Drives Q3 Earnings
Oct 16, 2024 · Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the company’s base business.
PRESS RELEASES - Abbott
View our press releases to learn about the latest Abbott nutrition news, research, and trusted brands, including Similac ®, PediaSure ®, Pedialyte ®, Ensure ®, Glucerna ®, ZonePerfect ® and more.
Abbott bumps up profit forecast on strong medical device sales
Oct 16, 2024 · (Reuters) -Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong demand for its continuous glucose...